SARcode Gets Series A
SARcode, a San Francisco-based biotechnology firm developing small molecule drugs for treating inflammatory disease, has raised a Series A round. The funding came as part of a licensing deal with South San Francisco-based Sunesis Pharmaceuticals last week. Amount of the Series A funding were not disclosed.
posted on Friday, January 12, 2007 (Link to more information)
Related companies:
SARcode
Related stories:
> SARcode Bioscience Acquired By Shire
> SARcode Bioscience Gets $44M
> Clarus Ventures Names Partners
> Rigetti Computing Gets $64M For Quantum Computing
> Virobay Gets $8M In Additional Series B
silicontap.com Home